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Characterization of avian natural killer cells and 
their intracellular CD3 protein complex* 
Natural killer (NK) cell activity appears to be conserved throughout vertebrate 
development but NK cells have only been well characterized in mammals. 
Candidate NK cells have been identified in the chicken as cytoplasmic CD3+ and 
surface T cell receptor (TCR)/CD3- (TCRO) lymphocytes that often express 
CD8.The fact that theTCRO cells are abundant in the embryonic spleen before 
T cells enter this organ allowed us to cultivate the embryonic TCRO cells using 
growth factors derived from activated adult lymphocytes.TheseTCR0 cells were 
cytotoxic for an NK target cell line. They expressed cell surface CD8, a putative 
interleukin-2 receptor, CD45 and a receptor for IgG, but did not express CD4, 
major histocompatibility complex class I1 or immunoglobulin. Biochemical 
analysis of the cytoplasmic CD3 antigen revealed two of the three CD3 y, 6 and 
E homologues, and RNA transcripts for the third.The CD3 monoclonal antibody 
also precipitated a 32-kDa dimer that may represent a heterodimer of different 
CD3 constituents. TCR a and p gene transcripts were not detected in the TCRO 
cells. These results indicate that the avian TCRO cell is the mammalian NK cell 
homologue.The shared evolutionary features of T cells and NK cells in birds and 
mammals support the idea that they derive from a common progenitor. 
1 Introduction 
A third lineage of lymphoid cells has been identified in the 
chicken that is developmentally independent of both the 
thymus and the bursa [ l ,  21. These cells are identified by 
their intracellular expression of a CD3 antigenic determi- 
nant and absence of TCR/CD3 determinants on the cell 
surface. Many of these cells express surface CD8, but none 
express CD4. These cells, called TCRO, first appear on 
embryonic day 8 (E8) in the spleen, 4 days before TCR+ 
cells appear in the thymus, and they rapidly increase in 
frequency to reach peak levels of approximately 10 YO of the 
splenocytes by E14. In adult birds, the TCRO cells are 
found mainly in the intestinal epithelium, where they 
comprise approximately 25 % of the CD3+ cells as detected 
in tissue sections. 
The thymus-independent development of TCRO cells was 
established in studies of interspecies chick-quail chimeras 
[l], taking advantage of mAb specific for chicken lympho- 
cyte antigens [3, 41. Splenic transplants from E6 chick 
embryos generate TCRO cells in quail recipients [l], 
whereas precursor cells do not enter the epithelial thymus 
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before E6.5 [5]. TCRO cells derived from the embryonic 
spleen fail to develop intoT or B cells, thus establishing this 
as a third lymphocyte lineage. 
The functional capabilities of theTCRO cells have not been 
determined, but the possibility that they may be NK cells is 
suggested by their phenotypic similarity with human NK 
cells [6-91. Moreover,TCRO cells are present in lymphoid 
tissues that have been shown to contain cells with NK 
activity [lo, 111. In order to characterize further the 
composition, nature and function of these candidate NK 
cells, it was necessary to isolate them in relatively large 
numbers. For this we have established a culture system for 
TCRO cells employing the E l4  splenocyte population, 
which contains an abundance of TCRO cells but virtually 
noT cells [2, 121. Functional, immunological and biochem- 
ical analyses of these TCRO cells indicate that they have 
NK activity and closely resemble mammalian NK cells in 
their phenotypic profile. 
2 Materials and methods 
2.1 Animals 
Fertile eggs of SC (B2B2) white leghorn chickens were 
obtained from Hy-Line International (Dallas Center, IA) 
and incubated at 41 "C. Embryonic age was estimated by the 
number of days of incubation. Chicks were hatched and 
raised in our animal facility. 
2.2 Monoclonal antibodies 
The CT3, CT4, CT8,TCR1, and TCR3 mAb, respectively 
defining the chicken CD3, CD4, CD8, ysTCR and Vp2- 
apTCR, were produced in our laboratory [12-161. The 
TCR2 mAb, specific for Vfll-aPTCR, and the mAb CL-1, 
specific for chicken CD45, were kindly provided by Drs. J. 
Cihak and U. Losch (Institute for Animal Physiology, 
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Munich, FRG) [ 17-19]. The TAP-1 mAb recognizing MHC 
class I1 molecules [20] was supplied by Dr. N. LeDouarin 
(Institut d' Ernbryologie, Nogent-sur-Marne, France). The 
Ch T6 mAb, which reacts with the putative chicken IL-2R 
[19,21], was provided by Dr. G.  Wick (Institut for General 
and Experimental Pathology, Innsbruck, Austria). The 
Ep42 mAb recognizing the CD8 p chain was provided by 
Michael Ratcliffe (McGill University, Montreal, Canada; 
[19] and Young, J. et al., unpublished). 
2.3 Cell l i e s  
TheTCR2+ Marek's disease virus-transformed cell (MDV) 
line UG9 was provided by Dr. L. W. Schierman (University 
of Georgia, Athens, GA); the TCR3+ CD132A MDV line 
and the avian leukosis virus-induced cell line LSCC-RP9 
were from Dr. K. A. Schat (Cornell University, Ithaca, 
New York); and BM2, an avian myeloblastosis virus- 
transformed macrophage cell line, was kindly provided by 
Dr. D. L. Ewert (Wistar Institute, Philadelphia, PA). All 
cell lines were grown in RPMI 1640 supplemented with 
15 YO FCS, L-glutamine (2 mM), penicillin (100 U/ml), 
streptomycin (100 pg/ml), nonessential amino acids (1 YO),  
sodium pyruvate (1 mM) and 2-ME (50 pM) (complete 
RPMI) at 41 "C. 
2.4 Culture of El4 spleen cells 
Single-cell suspensions were obtained by homogenizing 
El4 spleens between two frosted-end glass slides. Viable 
cells were isolated using a Ficoll-Hypaque (Pharmacia, 
Piscataway, NJ) gradient and the viability (> 95 %) was 
determined by trypan exclusion. Cells (1 X 106/ml) were 
cultured at 41 "C in 6-well plates containing complete RPMI 
and 10-20 % of a conditioned medium, which was changed 
daily when the cultures were split to maintain a cell density 
of 1 x 106/ml. The conditioned medium was prepared by 
culturing adult splenocytes (1 x 107/ml) in complete RPMI 
with 10 pg/ml Con A (Sigma, St. Louis, MO) for 48 h.The 
cytokine-containing SN was filtered through a 30-kDa filter 
(Amicon, Beverly, MA), sterilized by filtration and stored 
at - 20°C. 
2.5 lmmmunofluorescence analysis 
Cells were stained indirectly with the primary mAb fol- 
lowed by FITC-conjugated goat anti-mouse-Ig (Southern 
Biotechnology Associates, Birmingham, AL) before analy- 
sis on a FACScan flow cytometer as previously described 
[ 141. For cytoplasmic staining, cells (1 x lo6) were fixed for 
20 rnin at 4 "C with 10 YO phosphate-buffered formalde- 
hyde. After washing, the cell membrane was permeabilized 
by incubation with 0.125 YO Triton X-100 in PBS for 3.5 rnin 
at room temperature before immunofluorescence staining 
P I .  
2.6 IgG-binding assay 
Cells (1 x lo6) were incubated for 30 rnin at 4 "C with 30 p1 
(0.5 mg/ml) heat-aggregated chicken IgG [23]. After three 
washes in medium, cells were stained with FITC-conju- 
gated goat anti-chicken-y for 30 rnin at 4°C and then 
washed three times before analysis on a flow cytometer. 
2.7 Electron microscopic analysis 
After fixation with 1.25 9'0 glutaraldehyde in cacodylate 
buffer for 1 h at room temperature, cells were rinsed in 
cacodylate buffer, post-fixed for 1 h in 1 YO osmium tetrox- 
ide in the same buffer, subsequently dehydrated through a 
graded ethanol series and embedded in Spurr's medium 
[24]. Thin sections were stained with uranyl acetate and 
lead citrate and analyzed with a Philips 301 electron 
microscope. 
2.8 NK cell assay 
The NK-susceptible, target cell line LSCC-RP9 was used 
between passages 113 to 120, and the UG9 cell line was used 
as a control [25]. Target cells (5 x 106) of > 95 % viability 
were labeled with 60 pCi "'indium oxiquinoline solution 
(specific activity: > 50 mCi/pg indium; Amersham, Arling- 
ton Heights, IL) in 0.5 ml HBSS for 10 rnin at room 
temperature. The cells were washed three times and 
preincubated for 1 h at 41°C to reduce spontaneous 
release. After washing twice, target cells (2 x 104/100 PI) 
were placed in U-bottom 96-well microtiter plates and 
effector cells (100 pl) in various concentrations were added. 
Plates were spun at 50 x g for 5 min and incubated for 4 h 
at 41°C. Spontaneous release was measured by culturing 
target cells alone and the total release measured by lysing 
the cells with 0.5% NP40 followed by centrifugation at 
600 x g for 10 min. The spontaneous release never 
exceeded 12% of the total lllIn release. Specific release 
was calculated by the formula: specific release = [(test 
release-spontaneous release)/(total release - spontaneous 
release)] x 100. 
2.9 lmmunoprecipitation and gel electrophoresis 
Cytoplasmic proteins were labeled by incubating 5 x loh 
cells in methionine- and cysteine-free complete RPMI 
supplemented with dialyzed FCS, 100 pCi each of ["S] me- 
thionine and [35S] cysteine (Amersham, Arlington Heights, 
IL) for 4 h or 8 h at 41 "C. Cytoplasmic iodination was 
performed according to Anderson et al. [26]. Briefly, cells 
were fixed in 0.01 YO formaldehyde for 20 min, permeabi- 
lized with 8 p~ digitonin and then labeled by the lactoper- 
oxidase-catalyzed method with Na'251. The labeled cells 
were lysed with 1 YO NP40 in 0.05 M Tris-HCI pH 7.5 
containing protease inhibitors at 4°C for 30 rnin [27]. 
Lysates were immunoprecipitated by a solid-phase method 
in 96-well microtiter plates and absorbed molecules were 
eluted with 1 % SDS in 0.05 M Tris-HCI with or without 
2-ME [27]. Samples were electrophoresed on 12 YO gels as 
described [28] and the apparent molecular weight of 
precipitated molecules calculated according to molecular 
weight standards after autoradiography. 
2.10 Northern blot analysis 
Total RNA was prepared by the method of Chomczynski 
et al. [29]. Denatured samples were separated by agarose 
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gel electrophoresis and transferred to a nylon membrane 
(NEN, Boston, MA). Prehybridization was carried out in 
50 % formamide, 5 x SSC, 1 x Denhardt's, 0.5 % SDS, 
10 mM EDTA, 0.1 mg/ml salmon sperm DNA at 42 "C for 
6 h. Blots were subsequently hybridized under identical 
conditions with lo6 cpm random-primed DNA probe/ml. 
Washing was carried out in 0.2 x SSC, 0.1 % SDS at 68°C. 
cDNA probes employed for detection included those 
specific for the 19-kDa CD3 protein [30], the TCRa 
C region [31], the TCRB C region [32], and a probe specific 
for glyceraldehyde-3-phosphate dehydrogenase (GPDH) 
as a control of RNA integrity. 
3 Results 
3.1 Growth of TCRO cells from the embryonic spleen 
El4  splenocytes were grown in complete RPMI with or 
without growth factors from Con A-stimulated adult sple- 
nocytes in the initial experiments. In both cases, the 
cultures could be maintained for up to 1 week but cell 
proliferation was not observed even when the Con A was 
neutralized with a-MM. In contrast, the embryonic spleno- 
cyte cultures showed vigorous proliferation with a cell 
doubling time of approximately 36 to 48 h over the first 
10 days when cultured in the presence of the conditioned 
medium that was filtered with a 30-kDa membrane to 
remove large potentially inhibitory components. When 
cultured with this fractionated ConA SN, the embryonic 
spleen cells could be maintained for 3 to 4 weeks. 
The cultured E l4  splenocytes were lymphoid in morpholo- 
gy, and the frequency of CD8+ cells increased from 7 % to 
75% over 14days in culture (Fig. 1). The number of 
IL-2Rf cells similarly increased from approximately 25 YO 
to almost 90 YO. Two-color immunofluorescence analysis 
confirmed that essentially all of the IL-2Rf cells coexpress 
CD8 and vice versa (data not shown). On the other hand, 
these lymphoid cells did not express HMC class I1 mole- 
cules, and other types of MHC class 11-positive splenocytes 
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decreased from approximately 50 % to less than 10 % over 
the 2-week culture interval. Virtually all of the cells 
expressed CD45, whereas none of the cultured cells 
expressed cell surface CD4, CD28, IgM, TCR1, TCR2, 
TCR3 or CD3 (Fig. 1, data not shown).These data indicate 
that the expanded population of CD8+ IL-2R+ lymphoid 
cells in the E l4  splenocyte cultures were not T cells, B cells 
or monocytes. Furthermore, the CD8 antigen detected on  
these cells were CD8a+CD8P- (Fig. 2A). 
Although the CD3 antigen was not found on the cell surface 
(Fig. 2B), when the cells were permeabilized to allow 
detection of intracellular CD3, the frequency of CD3+ cells 
was similar to that of the CD8+ cells in most cultures 
(Fig. 2C), although the frequency of the cytoplasmic CD3+ 
surface CD8+ cells varied (data not shown). The coexpres- 
sion of intracellular CD3 and CD8 on the cell surface was 
confirmed by microscopic examination of cells stained for 
surface CD8 followed by cytoplasmic staining of CD3. 
These results indicate that TCRO cells from the El4  spleen 
can be expanded in culture with lymphocyte-derived 
cytokines, and theseTCRO cells retain most of their in vivo 
phenotypic characteristics. 
3.2 TCRO cells are granular lymphocytes 
TCRO cells displayed a consistent uniformity of morpho- 
logical features illustrated in Fig. 3. These lymphoid cells 
displayed irregular surfaces with long villi. The nuclear to 
cytplasmic ratio was low and several organelles were 
detected in the extended cytoplasm, including mitochon- 
dria, isolated profiles of the rough endoplasmic reticulum 
and small stacks of Golgi cisternae. Electron-dense gran- 
ules (primary lysosomes) were present, although not 
abundant, and were scattered in the cytoplasm. The nuclei 
were indented with Golgi vesicles present in the nuclear 
notch. 
3.3 TCRO cells can bind chicken IgG 
A prime characteristic of mammalian NK cells, which the 
avian TCRO cells resemble, is the expression of FcyR [33]. 
When the capacity to bind heat-aggregated chicken IgG 
was analyzed in an immunofluorescence assay, the TCRO 
A B C 
CD8 CD3 CD3 
Fiwre 2. Cultured TCRO cells express cell surface CD8a chains 
Figure 1. Cell surface antigen profile of El4 spleen cells in culture. 
Spleen cells from El4 embryos were cultured with low molecular 
weight cytokines derived from Con A-activated adult splenocytes 
and the expression of TCR1, TCR2, TCR3, CD3, CD8, MHC 
class I1 and IL-2R was analyzed by indirect immunofluorescence. 
Each point represents the mean f SD from three or more 
experiments. 
an2 intracellular CD3. Embryonic splenocytes cultured for 14 days 
were analyzed by indirect immunofluorescence for (A) cell surface 
reactivity with the CT8 mAb (anti-CD8a) or with EP42 mAb 
(anti-CDSfI), (B) cell surface expression of CD3 and (C) cytoplas- 
mic expression of CD3 after permeabilization with detergent. 
Dashed line indicate background staining with an isotype-matched 
control mAb of irrelevant specificity. 
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Figure 3. Ultrastructure of a TCRO cell. Note the indented 
nucleus. the extended cytoplasm with a variety of organelles 
including vesicles and electron-dense granules (arrows) in this 
lymphoid cell. Long villi protrude at one end of the cell 
( x  17300). 
cells were able to bind chicken IgG, suggesting the presence 
of IgG-R on their surface. Bursa1 cells and a macrophage 
cell line also demonstrated IgG-binding capacity as 
expected, whereas a T cell did not (Fig. 4). The staining 
profiles for IgG binding were very similar for TCRO and 
bursal cells, whereas a characteristic bimodal staining 
pattern was observed for the macrophage cell line. 
3.4 TCRO cells exhibit NK activity 
Since the TCRO cells phenotypically resemble mammalian 
NK cells, the El4 spleen cells cultured from SC chicks were 
assessed for cytotoxic capability in an "'indium oxiquino- 
line release assay employing the NK-susceptible cell line, 
LSCC-RP9 [ 2 5 ] .  Spontaneous cytotoxicity was observed 
against this NK target cell (Fig. 5A) with the highest level 
of cytotoxicity at an E/T ratio of 50-1OO:l. When adult 
splenocytes were analyzed for comparison, their capacity 
for spontaneous lysis was much lower. The UG9 T cell line 
lacked cytotoxicity for the LSCC-RP9 cells, and as a target 
cell line it was not killed by the TCRO cells (data not 
shown). When the level of NK activity was compared with 
the frequency of CD8+ cells in theTCRO cultures, a direct 
correlation was observed (Fig. 5B). 
TCRO I 
LSCC-BM2 
M( cell line 
T cell line 
Fluorescence Intensity 
Figure 4. TCRO cells can bind chicken IgG. Cultured El4 TCRO 
cells, the UG9 T cell line, the BM2 macrophage line, and normal 
bursal cells were incubated with heat aggregated chicken IgG. 
washed and stained by FITC-conjugated goat antibodies to chicken 
IgG before analysis by FCM. 
C u I tured u 
X 
.I 
E l 4  Spleen Cells T 0 15 r 
0 
h 
& 
u 10 
0 1 3 6 12 25 50 100 
Effector / Targe t  Ra t io  
3.5 Molecular analysis of CD3 and TcR expression by 
TCRO cells 
The gene encoding one of the three previously defined 
components of the chicken CD3 complex, the 19-kDa 
protein, has been cloned [30]. Using this cDNA probe, a 
1 .O-kb transcript was identified in af3 T cell lines and TCRO 
cells. In contrast, this CD3 transcript could not be detected 
in a macrophage cell line BM 2 ,  liver or brain (Fig. 6).When 
the Northern blot was rehybridized with probes specific for 
the TCRa or TCRP C regions, these TCR transcripts were 
identified inT cells, but were not present in theTCRO cells. 
10 20 30 40 50 60 
% CD8-positive Cells 
Figure 5. Cytotoxicity of TCRO cells. (A) TCRO cells lyse target 
cells in a dose-dependent fashion.The spontaneous cytotoxicity of 
El4 spleen cells cultured for 14 days, fresh adult spleen cells or the 
Tcell line UG9 were analyzed in a Il'In rclease assay using 
different E/T (LSCC-RP9) ratios as indicated. Each point repre- 
sents the mean k SD from five different experiments. (B) NK cell 
activity correlates with the frequency of CD8+ TCRO cells. 
Cultured El4 spleen cells harvested at different intervals were 
assayed for CD8expression and spontaneous cytotoxicity at an E/T 
ratio of 100: 1. Correlation coefficient: 0.96. 
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The protein components of the intracellular CD3 complex 
were analyzed by immunoprecipitation and PAGE of 
biosynthetically labeled proteins. After a 4-h labeling 
period, the same three proteins with apparent molecular 
weights of 32,20 and 17 kDa were precipitated from both a 
T cell line and embryonicTCRO cells (Fig. 7A). When the 
labeling period was extended to 8 h, an additional band of 
19 kDa was precipitated from T cells, whereas this band 
could not be demonstrated in TCRO cells even after the 
longer labeling interval. The protein bands of TCRO cells 
were consistently fainter, compared to T cells after the 8-h 
labeling period, probably because of rapid degradation of 
cytoplasmic CD3 proteins, that do not reach the cell 
surface. To overcome this problem, cytoplasmic proteins 
were labeled by iodination. When the CD3 immunopreci- 
pitates were analyzed on a 2-D gel, 4 and 5 protein spots 
were detected in TCRO cells and Tcells, respectively 
(Fig. 7B). T cells and TCRO cells contained identical CD3 
proteins of approximately 20 kDa on the diagonal and 
18 kDa migrating slightly above the diagonal, as well as two 
proteins of approximately 19 kDa and 18 kDa, with spots 
falling below the diagonal. An additional 17-kDa protein 
was observed on the diagonal in T cells but not in TCRO 
cells. 
CD3 
TCRa 
TCRP 
GPDH 
-1.0 
-1.3 
-1.7 
-1.6 
Figure 6. CD3 mRNA expression inTCRO cells.Total RNA from 
the TCR2+ UG9 cell line, the TCR3+ CU132A cell line, 14-day 
cultured TCRO cells, the macrophage cell line BM2, brain or liver 
were analyzed by Northern blot using cDNA probes as indi- 
cated. 
Human NK cell Chicken NK cell E; 0 0 . ... . ...  m a  
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Figure8. Schematic comparison of human and avian NK cells. 
Dashed lines represent molecules not yet defined. 
4 Discussion 
The comparative analysis of chicken TCRO cells suggests 
that they represent the avian homologue of mammalian NK 
cells (Fig. 8). Initially these cells were identified as a 
population of chick lymphocytes lacking the antigen recep- 
tors characteristic of theT and B cells, but which contain an 
intracellular CD3 epitope [2]. These so-called TCRO cells 
are generated outside of the thymus [l] and their early 
development in the embryonic spleen provided a tissue 
source virtually free of contaminating T and B cells. The 
acquisition of an enriched population of TCRO cells in 
sufficient numbers of phenotypic characterization was 
rendered possible by the demonstration that embryonic 
TCRO cells, like mammalian NK cells [34, 351, can be 
cultured for several weeks in the presence of low molecular 
weight growth factors supplied by activated T cells. The 
vast majority of the lymphoid cells that grew in the El4  
spleen cultures expressed CD3 intracellularly, CD8a chains 
on their surface, a binding site for chicken IgG and the 
50-kDa chain of a putative IL-2R that is found on activated 
T cells in the chicken [19,21]. The putative IL-2R may be 
an important element in their growth, since IL-2 is one of 
the growth factors present in SN of Con A-activated 
chicken splenocytes [36, 371. Human NK cells constitutive- 
ly express an intermediate IL-2R composed of p and y 
chains, and after activation they also express the 55-kDa a 
chain to form the high affinity IL-2R [38, 391. Like 
mammalian NK cells and their in vivo counterparts, the 
cultured TCRO cells lack both CD4 and the antigen 
receptors characteristic of T and B cells. In contrast with 
human NK cells [33], the avian TCRO cells do not express 
MHC class I1 and, in this way, resemble rat NK cells [40]. 
CD3 
-1 6 
-1 4 TCRO cels- 
B 
CD3 
- 97 
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Figure 7. CD3 proteins in T cells and TCRO cells. UG9 T cells or 14 day cultured TCRO cells were metabolically labeled with 
[3%] methionine and 135S] cysteine (A) or intracytoplasmically iodinated (B). Cell lysates were immunoprecipitated with either an isotype 
control mAb or the (3 '3  mAb as indicated and analyzed on 12 % SDS gels under (A) nonreducing conditions or (B) on a 2-D gel. 
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Although only half of the TCRO cells express CD8 
molecules in the chicken [2], a vast majority of the TCRO 
cells in culture were CD8+. In mammals CD8 expression 
has been reported on rat [40] and some human NK cells 
[41], but not on mouse NK cells [33].The mammalian CD8 
antigen exists in two different forms, an aa homodimer and 
an af3 heterodimer. Whereas the latter is found on most 
T cells, the former is expressed on many y6 T cells and on 
NK cells [42]. The TCRO cells react with the anti-CD8a 
mAb, but not with the mAb EP-42, specific for the chicken 
CD86 chain [19], suggesting the presence of a CD8aa 
homodimer. 
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The lymphoid cells in the El4 spleen cultures displayed the 
typical granular lymphocyte morphology of NK cells [33] 
and exhibited spontaneous cytotoxicity for an established 
NK cell target, the LSCC-RP9 tumor cell line [25]. While 
the avian NK target cell appears more resistant to lysis than 
the classical mammalian K562 cell target, like mammalian 
NK cells the TCRO cells lacked cytotoxicity for T cells.The 
level of NK activity was found to be directly proportionate 
to the frequency of CD8+ lymphocytes in the embryonic 
splenocyte cultures. These results, together with the phe- 
notypic profile, clearly imply that theTCRO cells represent 
the avian NK homologue. 
The intracellular presence of CD3 proteins is an intriguing 
feature of NK cells. Transcripts encoding the 19-kDa CD3 
protein were readily detectable inTCRO cells, despite their 
lack of a(3 TCR chain-specific transcripts (Fig. 6). However, 
protein analysis revealed the presence of two CD3 protein 
chains of 20 and 17 kDa but undetectable levels of the 
19-kDa chain (Fig. 7A). 2-D gel analysis confirmed the 
presence of the 20-kDa protein on the diagonal and another 
protein above the diagonal in both Tand TCRO cells. The 
characteristic migration pattern above the diagonal is 
typical of the mammalian C D ~ E  chains because of intra- 
chain disulfide bonds (Fig. 7B). A third protein observed in 
T cells could not be detected in TCRO cells. 
Adult human NK cell clones have been shown to express 
CD3e and CD31; transcripts but no  TCR proteins [6, 71. 
However, NK cell clones established from human embryos 
have been shown to contain the C D ~ E ,  CD36 and CD3y 
proteins, although the latter was found only in certain 
clones where the CD3y protein chains were present in low 
levels as an immature, partially-glycosylated species [8, 91. 
The chicken 19-kDa chain appears to be the CD3y 
counterpart that is either present in very low amounts in 
avian NK cells or in an immature form that co-migrates with 
the 17-kDa band on SDS-gels.TheTCR0 cells grown from 
El4 chick embryos are thus very similar to human fetal NK 
cells in their intracellular expression of CD3 proteins 191. 
A 32-kDa dimeric component (reduced to 19-kDa and 
18-kDa proteins falling below the diagonal on the 2-D gel; 
Fig. 7B) of the CD3 complex was also detected in TCRO 
and T cells.This heterodimer may represent the association 
of two CD3 chains. Alternatively the heterodimer could be 
formed by members of the CD3 t family, which typically 
form hetero- or homodimers of similar molecular weights in 
CD3 complexes. However, in T cells the CD31; proteins 
normally are associated only with TCR/CD3 complexes, 
which are not present in TCRO cells. It might be postu- 
lated, though. that some yet unidentified components form 
complexes with the CD3 chains in NK cells. These com- 
plexes could associate with the CD3t members. At present, 
it is impossible to identify this heterodimer, since reagents 
detecting each of the avian CD3 chains are not available. 
On mammalian NK cells the CD3 1; chain is also associated 
with FcyFUIIA (CD16) as a disulfide-linked C-5 homodimer 
or a heterodimer of 5 and the FceRI y chain [6, 7, 43].The 
binding of chicken IgG by TCRO cells suggests the 
existence of a FcyR (CD16) homologue in the chicken, and 
emphasize the need to define this receptor unit. 
The presence of the CD3 complex of proteins in both NK 
and T cells, reinforces the idea of a common developmental 
origin. Although TCR expression clearly distinguishes 
T cells from NK cells, other phenotypic similarities, such as 
their responsiveness to IL-2 and cytotoxic capabilities, 
suggest they are close relatives [44,45] in spite of the fact 
that NK cells are developmentally independent of the 
thymus. However, NK and T cell precursors can be found in 
the thymus [45-481 and the FcyRII/RIII+ thymocyte 
population in fetal mice includes precursors that give rise to 
matureT cells in the thymus and NK cells in an extrathymic 
environment [49]. The identification of the CD3 protein 
complex in avian NK cells thus favors the speculation that 
T cells and NK cells may derive from a common ancestral 
precursor. The preservation of this intracellular complex in 
NK cells over more than 250 million years in vertebrate 
evolution could merely represent a prehistoric relic, but it 
seems likely that the CD3 proteins will prove to have 
functional significance in the NK cells. 
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